In conclusion, this study demonstrated that NLGN3 which is elevated in malignant GBM cell lines plays a critical role in CSCs properties in which Wnt/β-catenin signaling pathway is further defined as a key underlying mechanism. This evidence concerns the gene NLGN3 and glioblastoma.